<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00723944</url>
  </required_header>
  <id_info>
    <org_study_id>2302</org_study_id>
    <nct_id>NCT00723944</nct_id>
  </id_info>
  <brief_title>A Study of the Performance of Certain Prevail Implants Used in Short Fixed Cases</brief_title>
  <acronym>RadioCity</acronym>
  <official_title>A Prospective, Randomized-controlled Multicenter Study of the Osseotite Certain Lateralized Implanting Short-span Fixed Bridge Cases for Preservation of Crestal Bone</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective, randomized study evaluates the performance and crestal bone changes
      difference between the Osseotite Certain Prevail vs the non-lateralized design of the
      implant.

      Study (null) hypothesis: the crestal bone changes that take place after placement and loading
      of the Osseotite lateralized implants will be the same as for similar but non-lateralized
      Osseotite Certain implants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, randomized-controlled study where patients with qualifying partial
      edentulism received a short fixed bridge restoration. Each implant site was randomized to
      receive either the test (Osseotite Certain Prevail) or the control non lateralized version of
      the Osseotite Certain implant. All implants were placed in a single-stage manner with
      temporary provisionalization taking place two months after implant placement. Enrollment
      continued until 10 patients (approximately 30 implants) were treated at each participating
      study center.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2005</start_date>
  <completion_date type="Actual">May 2011</completion_date>
  <primary_completion_date type="Actual">April 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Crestal Bone Regression (Amount of Bone Measured) Around Each Implant Unit</measure>
    <time_frame>1 year</time_frame>
    <description>Millimeters of crestal bone observed and measured in a radiograph of each study implant is measured and averaged to obtain the mean crestal bone loss or gain for each implant unit.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Osseous Integration</measure>
    <time_frame>4 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">102</enrollment>
  <condition>Partial Edentulism</condition>
  <condition>Tooth Disease</condition>
  <arm_group>
    <arm_group_label>Osseotite Certain Prevail</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dental implant with lateralized design</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Osseotite Certain</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Dental implant without the lateralized design</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Osseotite Certain Prevail</intervention_name>
    <description>Root form titanium dental implant</description>
    <arm_group_label>Osseotite Certain Prevail</arm_group_label>
    <other_name>Osseotite</other_name>
    <other_name>Certain</other_name>
    <other_name>Prevail</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Osseotite Certain</intervention_name>
    <description>Dental implant without the lateralized design</description>
    <arm_group_label>Osseotite Certain</arm_group_label>
    <other_name>Osseotite</other_name>
    <other_name>Certain</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients of either sex and any race greater than 18 years of age

          -  patients for whom a decision has already been made to use dental implants for treating
             an existing dental condition specifically: a partially edentulous short fixed case of
             less than 4 implants in the maxilla or mandible; no cantilevers are allowed, but one
             interior crown may be a pontic

          -  patients must be physically able to tolerate conventional surgical and restorative
             procedures

          -  patients must agree to be evaluated for each study visit, especially the yearly
             follow-up visit

        Exclusion Criteria:

          -  patients with active infection or severe inflammation in the areas intended for the
             implants

          -  patients with more than 10 cigarette per day smoking habit

          -  patients with uncontrolled diabetes mellitus

          -  patients with metabolic bone disease

          -  patients who have had treatment with therapeutic radiation to the head within the past
             12 months

          -  patients in need of allogenic bone grafting at the site of the intended study implant

          -  patients who are pregnant at the screening visit

          -  patients with evidence of severe para-functional habits such as bruxing or clenching

          -  patients with cantilevers and more than one pontic per bridge
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anton Friedmann, DMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Charite- Zentrum fur Zahnmedizin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Charite- Universitatsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>D-10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 25, 2008</study_first_submitted>
  <study_first_submitted_qc>July 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2008</study_first_posted>
  <results_first_submitted>June 26, 2009</results_first_submitted>
  <results_first_submitted_qc>October 17, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">November 22, 2011</results_first_posted>
  <last_update_submitted>March 20, 2017</last_update_submitted>
  <last_update_submitted_qc>March 20, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dental implants</keyword>
  <keyword>Osseotite Certain Prevail</keyword>
  <keyword>Lateralized</keyword>
  <keyword>non-lateralized</keyword>
  <keyword>Osseotite Certain</keyword>
  <keyword>multicenter</keyword>
  <keyword>randomized</keyword>
  <keyword>clinical study</keyword>
  <keyword>partial edentulism</keyword>
  <keyword>single stage</keyword>
  <keyword>early loading</keyword>
  <keyword>crestal bone level</keyword>
  <keyword>short fixed bridge</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tooth Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
    <mesh_term>Povidone-Iodine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>A minimum of 100 patients were enrolled across all participating centers, with enrollment beginning in January 2005. Enrollment period remained open until April 2006. Three participating sites were Universities and seven were private practices.</recruitment_details>
      <pre_assignment_details>Pre-treatment included a screening visit (enroll those meeting all inclusion criteria), signing informed consent, and pre-surgical data collection.Patients returned for implant placement surgery, followed by temporary prosthesis placement at 2 months.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Osseotite Certain Prevail Implant</title>
          <description>Patients with dental implant with internal connection and expanded, lateralized design at coronal portion</description>
        </group>
        <group group_id="P2">
          <title>Osseotite Certain Implant</title>
          <description>Patients with dental implant with internal connection and without the expanded, lateralized design at coronal portion</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Implant Placement Surgery</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="52">number of individual implant units is 148</participants>
                <participants group_id="P2" count="50">number of individual implant units is 138</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="52">number of individual implant units completing is 148</participants>
                <participants group_id="P2" count="50">number of individual implant units completing is 138</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Permanent Prosthesis Placement</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="52">number of individual implant units is 148</participants>
                <participants group_id="P2" count="50">number of individual implant units is 138</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="49">number of individual implant units completing is 134</participants>
                <participants group_id="P2" count="41">number of individual implant units completing is 112</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>One Year Post Placement Follow-up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="49">number of individual implant units is 134</participants>
                <participants group_id="P2" count="41">number of individual implant units is 112</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48">number of individual implant units completing is 130</participants>
                <participants group_id="P2" count="37">number of individual implant units completing is 108</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Two Year Post Placement Follow-up</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48">number of individual implant units is 130</participants>
                <participants group_id="P2" count="37">number of individual implant units is 108</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48">number of individual implant units completing is 130</participants>
                <participants group_id="P2" count="37">number of individual implant units completing is 108</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Osseotite Certain Prevail Implant</title>
          <description>Patients with dental implant with internal connection and expanded, lateralized design at coronal portion</description>
        </group>
        <group group_id="B2">
          <title>Osseotite Certain Implant</title>
          <description>Patients with dental implant with internal connection and without the expanded, lateralized design at coronal portion</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="52"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="40"/>
                    <measurement group_id="B2" value="38"/>
                    <measurement group_id="B3" value="78"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="19"/>
                    <measurement group_id="B3" value="40"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Italy</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>France</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Germany</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sweden</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Crestal Bone Regression (Amount of Bone Measured) Around Each Implant Unit</title>
        <description>Millimeters of crestal bone observed and measured in a radiograph of each study implant is measured and averaged to obtain the mean crestal bone loss or gain for each implant unit.</description>
        <time_frame>1 year</time_frame>
        <population>population represents all patients receiving test and control implants enrolled in the study, but only those implants achieving integration (lack of mobility) were analyzed and reported here up to the 12 months follow-up stage.</population>
        <group_list>
          <group group_id="O1">
            <title>Osseotite Certain Prevail Implant</title>
            <description>Patients with dental implant with internal connection and expanded, lateralized design at coronal portion</description>
          </group>
          <group group_id="O2">
            <title>Osseotite Certain Implant</title>
            <description>Patients with dental implant with internal connection and without the expanded, lateralized design at coronal portion</description>
          </group>
        </group_list>
        <measure>
          <title>Crestal Bone Regression (Amount of Bone Measured) Around Each Implant Unit</title>
          <description>Millimeters of crestal bone observed and measured in a radiograph of each study implant is measured and averaged to obtain the mean crestal bone loss or gain for each implant unit.</description>
          <population>population represents all patients receiving test and control implants enrolled in the study, but only those implants achieving integration (lack of mobility) were analyzed and reported here up to the 12 months follow-up stage.</population>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <units_analyzed>implants</units_analyzed>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="37"/>
              </count_list>
            </analyzed>
            <analyzed>
              <units>implants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="130"/>
                <count group_id="O2" value="108"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.7705" spread="0.1567"/>
                    <measurement group_id="O2" value="-0.6648" spread=".1158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Osseous Integration</title>
        <time_frame>4 years</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event reporting is collected from day of the study to present, currently 4 years study duration.</time_frame>
      <desc>Adverse event data is collected by patient questionaire and visual inspection (assessment) of patient's mouth during each study event visit.</desc>
      <group_list>
        <group group_id="E1">
          <title>Osseotite Certain Prevail Implant</title>
          <description>Patients with dental implant with internal connection and expanded, lateralized design at coronal portion</description>
        </group>
        <group group_id="E2">
          <title>Osseotite Certain Implant</title>
          <description>Patients with dental implant with internal connection and without the expanded, lateralized design at coronal portion</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 12.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="52"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Loss of implant integration</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="52"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>PI shall furnish SPONSOR with a copy of any proposed publication thirty (30) days prior to submission for publication for review and comment. SPONSOR may request PI to delay publishing such proposed publication for a maximum of an additional sixty (60) days in order to protect the potential patentability of any invention described therein.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clinical Research Manager</name_or_title>
      <organization>Biomet 3i LLC</organization>
      <phone>5617766722</phone>
      <email>cristina.matthews@biomet.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

